These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 36750982)

  • 1. Growth Trajectories in Stimulant-Treated Children Ages 6 to 12: An Electronic Medical Record Analysis.
    Biederman J; DiSalvo M; Green A; Hutt Vater C; Driscoll H; Faraone SV
    J Dev Behav Pediatr; 2023 Feb-Mar 01; 44(2):e80-e87. PubMed ID: 36750982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attention deficit disorder, stimulant use, and childhood body mass index trajectory.
    Schwartz BS; Bailey-Davis L; Bandeen-Roche K; Pollak J; Hirsch AG; Nau C; Liu AY; Glass TA
    Pediatrics; 2014 Apr; 133(4):668-76. PubMed ID: 24639278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex-Specific Long-Term Height and Body Mass Index Trajectories of Children Diagnosed with Attention-Deficit/Hyperactivity Disorder and Treated with Stimulants.
    Yackobovitch-Gavan M; Mimouni-Bloch A; Gabbay U; Carmi D; Goldstein B; Keinan-Boker L; Bloch S; Meyerovitch J
    J Pediatr; 2021 Nov; 238():296-304.e4. PubMed ID: 34293373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth Trajectories in Stimulant Treated Children and Adolescents: A Qualitative Review of the Literature from Comprehensive Datasets and Registries.
    Hutt Vater C; Biederman J; DiSalvo M; O'Connor H; Parker H; Woodworth KY; Wozniak J; Faraone SV
    J Child Adolesc Psychopharmacol; 2023 Nov; 33(9):344-355. PubMed ID: 37966364
    [No Abstract]   [Full Text] [Related]  

  • 5. Further evidence of low adherence to stimulant treatment in adult ADHD: an electronic medical record study examining timely renewal of a stimulant prescription.
    Biederman J; Fried R; DiSalvo M; Woodworth KY; Biederman I; Driscoll H; Noyes E; Faraone SV; Perlis RH
    Psychopharmacology (Berl); 2020 Sep; 237(9):2835-2843. PubMed ID: 32591937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attention-Deficit/Hyperactivity Disorder Medication Treatment Impact on Response to Growth Hormone Therapy: Results from the ANSWER Program, a Non-Interventional Study.
    Rose SR; Reeves G; Gut R; Germak J
    J Pediatr; 2015 Dec; 167(6):1389-96. PubMed ID: 26394822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of Changes in Height, Weight, and Body Mass Index After Initiation of Central Nervous System Stimulants in Children with Attention Deficit Hyperactivity Disorder.
    Waxmonsky JG; Pelham WE; Baweja R; Hale D; Pelham WE
    J Pediatr; 2022 Feb; 241():115-125.e2. PubMed ID: 34571023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence of Low Adherence to Stimulant Medication Among Children and Youths With ADHD: An Electronic Health Records Study.
    Biederman J; Fried R; DiSalvo M; Storch B; Pulli A; Woodworth KY; Biederman I; Faraone SV; Perlis RH
    Psychiatr Serv; 2019 Oct; 70(10):874-880. PubMed ID: 31242830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trajectories of Growth Associated With Long-Term Stimulant Medication in the Multimodal Treatment Study of Attention-Deficit/Hyperactivity Disorder.
    Greenhill LL; Swanson JM; Hechtman L; Waxmonsky J; Arnold LE; Molina BSG; Hinshaw SP; Jensen PS; Abikoff HB; Wigal T; Stehli A; Howard A; Hermanussen M; Hanć T;
    J Am Acad Child Adolesc Psychiatry; 2020 Aug; 59(8):978-989. PubMed ID: 31421233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ADHD, stimulant treatment, and growth: a longitudinal study.
    Harstad EB; Weaver AL; Katusic SK; Colligan RC; Kumar S; Chan E; Voigt RG; Barbaresi WJ
    Pediatrics; 2014 Oct; 134(4):e935-44. PubMed ID: 25180281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Randomized Controlled Trial of Interventions for Growth Suppression in Children With Attention-Deficit/Hyperactivity Disorder Treated With Central Nervous System Stimulants.
    Waxmonsky JG; Pelham WE; Campa A; Waschbusch DA; Li T; Marshall R; Babocsai L; Humphery H; Gnagy E; Swanson J; Hanć T; Fallahazad N; Pelham WE
    J Am Acad Child Adolesc Psychiatry; 2020 Dec; 59(12):1330-1341. PubMed ID: 31473291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth and Puberty in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder.
    Banaschewski T; Johnson M; Nagy P; Otero IH; Soutullo CA; Yan B; Zuddas A; Coghill DR
    CNS Drugs; 2018 May; 32(5):455-467. PubMed ID: 29790103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost effectiveness of guanfacine extended release as an adjunctive therapy to a stimulant compared with stimulant monotherapy for the treatment of attention-deficit hyperactivity disorder in children and adolescents.
    Sikirica V; Haim Erder M; Xie J; Macaulay D; Diener M; Hodgkins P; Wu EQ
    Pharmacoeconomics; 2012 Aug; 30(8):e1-15. PubMed ID: 22788263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistence of stimulants in children and adolescents with attention-deficit/hyperactivity disorder.
    Palli SR; Kamble PS; Chen H; Aparasu RR
    J Child Adolesc Psychopharmacol; 2012 Apr; 22(2):139-48. PubMed ID: 22364400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of Stimulant Medications on Blood Pressure and Body Mass Index in Children with Attention Deficit Hyperactivity Disorder.
    Suess M; Chrenka EA; Kharbanda EO; Asche S; O'Connor PJ; Ekstrom H; Benziger CP
    Acad Pediatr; 2024 Apr; 24(3):424-432. PubMed ID: 37652161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of lisdexamfetamine dimesylate treatment for ADHD on growth.
    Faraone SV; Spencer TJ; Kollins SH; Glatt SJ
    J Am Acad Child Adolesc Psychiatry; 2010 Jan; 49(1):24-32. PubMed ID: 20215923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose Adjustment of Stimulants for Children with Attention-Deficit/Hyperactivity Disorder: A Retrospective Chart Review of the Impact of Exceeding Recommended Doses.
    Ross L; Sapre V; Stanislaus C; Poulton AS
    CNS Drugs; 2020 Jun; 34(6):643-649. PubMed ID: 32300972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of weight loss in children with attention deficit hyperactivity disorder treated with stimulant medication.
    Schertz M; Adesman AR; Alfieri NE; Bienkowski RS
    Pediatrics; 1996 Oct; 98(4 Pt 1):763-9. PubMed ID: 8885958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacotherapy for incident attention-deficit/hyperactivity disorder: practice patterns and quality metrics.
    Bussing R; Narwaney KJ; Winterstein AG; Newton DA; DeBar L; Boscarino JA; Toh S; Pawloski P; Nordin JD; Herrinton LJ; Mason D; Daley MF
    Curr Med Res Opin; 2014 Aug; 30(8):1687-99. PubMed ID: 24635013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal Trends in the Diagnosis of Attention-Deficit/Hyperactivity Disorder and Stimulant Use in Preschool Children on Medicaid.
    Davis DW; Feygin Y; Creel L; Williams PG; Lohr WD; Jones VF; Le J; Pasquenza N; Ghosal S; Jawad K; Yan X; Liu G; McKinley S
    J Pediatr; 2019 Apr; 207():185-191.e1. PubMed ID: 30545564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.